Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 3 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Recs

0
Player Avatar modestus1 (< 20) Submitted: 5/22/2011 7:26:29 PM : Outperform Start Price: $55.05 VRTX Score: +17.71

blockbuster drug

Report this Post Reply

Featured Broker Partners


Advertisement